P53 germline mutations in childhood cancers and cancer risk for carrier individuals
about
Genetic causes of cancer predisposition in children and adolescentsSomatic mutagenesis in autoimmunitySolid tumor second primary neoplasms: who is at risk, what can we do?p53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum ConceptGenetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineRealizing the promise of cancer predisposition genes.An information-theoretic analysis of genetics, gender and age in cancer patientsIdentification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome.Germline mutations and polymorphisms in the origins of cancers in women.The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.Childhood adrenocortical tumours: a review.Single-nucleotide polymorphisms in the p53 signaling pathway.Map making in the 21st century: charting breast cancer susceptibility pathways in rodent models.An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.Effects of measured susceptibility genes on cancer risk in family studies.Evaluation of a decision aid for families considering p53 genetic counseling and testing.Clinical management of hereditary breast cancer syndromes.Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion.Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome.Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.10 rare tumors that warrant a genetics referral.Hereditary cancer risk assessment: essential tools for a better approach.siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.Breast cancer in young womenContralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.Lobular breast cancer: incidence and genetic and non-genetic risk factors.The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neckGermline TP53 mutational spectrum in French Canadians with breast cancer.The benefit and burden of cancer screening in Li-Fraumeni syndrome: a case reportPrimed for cancer: Li Fraumeni Syndrome and the pre-cancerous nicheCancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.Familial aggregation of urinary tract and bone tumors: searching for a syndrome.Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma.p53 and disease: when the guardian angel fails.Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma
P2860
Q26770339-2B893987-56AD-4997-9E7E-74CFF407281AQ26860815-D7A83918-C0D5-4505-9970-70509C42CBBCQ27026266-70260F20-3FFB-491F-B802-14CFDE7B1EA3Q28079390-B21F4CA4-B2DA-4CB2-B5D7-14867F89C164Q30513982-8059598A-73A8-4EAE-9B83-0BAD2C997CE7Q30743260-BBCFCFA4-F3E0-4CFE-BF68-A111A5FAC15CQ33327370-CBFBC701-0CC5-49D4-8A00-FF37D9DDF2C7Q33589744-8A65BBD4-0AB0-4C86-B6F0-430F3F755ADAQ33606675-E95FC7B6-DA81-4441-8753-64A0C66EF0EBQ33615771-735DF811-50F5-4DC6-B4C1-91F2BBD69B54Q33722503-60A1A4AA-D282-46BD-A4A3-0666F37F3BE7Q33800384-E4946902-2747-4861-8646-F18919E43A22Q33908246-022C115D-7B4C-470C-BC94-75C63C809366Q33930947-C60259EA-FEFA-466C-A5F9-B6BBE23D6859Q34052361-255902C5-9B55-4C65-A718-992353589A0DQ34093171-F8379698-4E6A-4D5D-BDD0-DC6CF46B323CQ34167563-7DBA4CBE-F0DA-420C-A500-77126E2AC0C0Q34294432-74A72A51-3B8B-44C4-AC8A-F58CE0DBE540Q34301309-AD1B1AF0-DE1C-42B7-8C3E-802D4756A404Q34306492-0FCE587B-64F4-4F9A-8C51-E9BCA0BA574AQ34324382-F3F3A0FA-BD27-44B8-B1F2-AA4CAA6A881CQ34324683-B8091646-AFF0-4945-AD79-A759FBCC8A00Q34325954-0B559732-E387-4C4A-A0BE-1F9C8E958FEFQ34507839-C14939F6-3E0F-470F-9982-1D55F51F27D4Q34597425-83D640BB-1472-48A3-91AF-9BB09EF3C983Q34989073-ABF71723-5087-4D0E-B242-799A1543E7DEQ35066801-395D432D-6F28-442A-9ED1-CDE58ABF0DCFQ35077001-B3914592-799E-41A0-BC15-897103350CF0Q35170028-7B80DBE9-8997-4C14-8634-142AE01F0244Q35448964-6D45515D-856B-4D39-91EC-4EB613D6FC63Q35618321-7153F1B6-E0CF-4EFF-B6B3-882555360FC3Q35652714-CEF23FE3-B1DD-4A8D-8503-E0B82F5A679DQ35717532-B38B283F-B295-483B-9FAC-95E106D5122EQ35894536-2A3B6900-0964-4D78-8E28-28DA1C485A19Q35896015-2A3D6F42-7588-4E71-90AB-C23AA1BED6C6Q35996606-DD3969DE-D9E9-462C-BE35-D4B2800427F2Q36169808-EFAB24D2-C75E-47E3-88EB-878826FC7E4FQ36430165-151F6569-5026-408B-8024-AB5494BE7C7CQ36475859-0F41622B-4902-4563-B44F-D255214612BFQ36508843-3DCCD43F-7772-400A-8D70-433500E46F7B
P2860
P53 germline mutations in childhood cancers and cancer risk for carrier individuals
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
P53 germline mutations in childhood cancers and cancer risk for carrier individuals
@ast
P53 germline mutations in childhood cancers and cancer risk for carrier individuals
@en
type
label
P53 germline mutations in childhood cancers and cancer risk for carrier individuals
@ast
P53 germline mutations in childhood cancers and cancer risk for carrier individuals
@en
prefLabel
P53 germline mutations in childhood cancers and cancer risk for carrier individuals
@ast
P53 germline mutations in childhood cancers and cancer risk for carrier individuals
@en
P2093
P2860
P356
P1476
P53 germline mutations in childhood cancers and cancer risk for carrier individuals
@en
P2093
Bonaïti-Pellié C
Bressac-de Paillerets B
Brugières L
Chompret A
Dessarps-Freichey F
Feunteun J
Frébourg T
P2860
P2888
P304
P356
10.1054/BJOC.2000.1167
P407
P577
2000-06-01T00:00:00Z
P5875
P6179
1034143500